Drug Products: Biologics, Biosimilars and Interchangeables
FDA Approved Drugs: Changes to Approved Drugs
Drug Discovery: Overview
Synthetic Biology
Drug Nomenclature
Structure-Activity Relationships and Drug Design
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 23, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
Andrew C Flick1, Carolyn A Leverett2, Hong X Ding3
1Takeda California, Inc., 9625 Towne Centre Drive, San Diego, California 92121, United States.
This review details the synthetic strategies for 39 new chemical entities (NCEs) approved in 2018. It highlights their potential as privileged structures for drug design and understanding molecular recognition.
Area of Science:
Background: